KIR2DL3 and infection: Notably, lack of HLA-C1 expression in KIR2DL3/2DS2+ SOT recipients or donors is associated with increased risk of CMV viremia [65], suggesting that KIR2DL3/HLA-C1 interactions may be protective during infection.